EE56 Minimally Invasive Surfactant Treatment Versus Standard Therapy in Preterm Infants at Birth (OPTIMIST-A TRIAL): An Analysis of Initial Hospitalisation Costs and Resource Consumption

I. Cox,B. de Graaff, P. Otahal, O. Kamlin, F. Orsini, A. De Paoli, H. Clark,R. Soll,J. Carlin, P. Davis, P. Dargaville,A.J. Palmer

Value in Health（2023）

引用 0|浏览3

暂无评分

摘要

To compare the per capita costs of initial hospitalisation in infants receiving minimally invasive surfactant therapy (MIST) or standard treatment (ST) using data from a multicentre blinded parallel group RCT (OPTIMIST-A trial, JAMA 2021, 326:2478).

查看译文

关键词

preterm infants,initial hospitalisation costs,birth

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要